Online inquiry

IVTScrip™ mRNA-Human ATP10A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28772MR)

This product GTTS-WK28772MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ATP10A protein. This product can be used in Multilymphoid progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_024490.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 57194
UniProt ID O60312
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ATP10A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28772MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK8442MR IVTScrip™ mRNA-Human ABCB8, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ABCB8
GTTS-WK21879MR IVTScrip™ mRNA-Human ATP13A2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ATP13A2
GTTS-WK25743MR IVTScrip™ mRNA-Human ATCAY, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ATCAY
GTTS-WK8134MR IVTScrip™ mRNA-Human ABCA5, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ABCA5
GTTS-WK0427MR IVTScrip™ mRNA-Human SLC16A1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA SLC16A1
GTTS-WK18429MR IVTScrip™ mRNA-Human ALMS1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ALMS1
GTTS-WK6888MR IVTScrip™ mRNA-Human MGARP, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA MGARP
GTTS-WK23392MR IVTScrip™ mRNA-Human ATP2B4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATP2B4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →